Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S. Boers M, et al. Among authors: van de laar ma, van denderen jc, van zeben d, van den brink hr, van der heijde dm, van der linden s. Lancet. 1997 Aug 2;350(9074):309-18. doi: 10.1016/S0140-6736(97)01300-7. Lancet. 1997. PMID: 9251634 Clinical Trial.
The main outcomes were the pooled index (a weighted change score of five disease activity measures) and the Sharp/Van der Heijde radiographic damage score in hands and feet. ...
The main outcomes were the pooled index (a weighted change score of five disease activity measures) and the Sharp/Van der Heijde radi …
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.
Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE. Kuijper TM, et al. Among authors: van zeben d. Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9. Ann Rheum Dis. 2016. PMID: 27283332 Clinical Trial.
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.
de Jong PH, Hazes JM, Barendregt PJ, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE. de Jong PH, et al. Among authors: van zeben d, van der lubbe pa. Ann Rheum Dis. 2013 Jan;72(1):72-8. doi: 10.1136/annrheumdis-2011-201162. Epub 2012 Jun 7. Ann Rheum Dis. 2013. PMID: 22679301 Clinical Trial.
Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use.
van Zeben D, Hazes JM, Vandenbroucke JP, Dijkmans BA, Cats A. van Zeben D, et al. Arthritis Rheum. 1990 Oct;33(10):1462-5. doi: 10.1002/art.1780331002. Arthritis Rheum. 1990. PMID: 2222531 Clinical Trial.
Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study.
van Zeben D, Hazes JM, Zwinderman AH, Cats A, Schreuder GM, D'Amaro J, Breedveld FC. van Zeben D, et al. Among authors: d amaro j. Arthritis Rheum. 1991 Jul;34(7):822-30. doi: 10.1002/art.1780340707. Arthritis Rheum. 1991. PMID: 2059230
Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.
van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC. van Zeben D, et al. Among authors: van der voort ea. Ann Rheum Dis. 1992 Sep;51(9):1029-35. doi: 10.1136/ard.51.9.1029. Ann Rheum Dis. 1992. PMID: 1417131 Free PMC article.
Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study.
van Zeben D, Giphart MJ, Christiansen FT, Hoetjer M, Meyer EC, Breedveld FC. van Zeben D, et al. Hum Immunol. 1992 Feb;33(2):148-51. doi: 10.1016/0198-8859(92)90066-v. Hum Immunol. 1992. PMID: 1563983
Prognostic factors in rheumatoid arthritis.
van Zeben D, Breedveld FC. van Zeben D, et al. J Rheumatol Suppl. 1996 Mar;44:31-3. J Rheumatol Suppl. 1996. PMID: 8833048 Review.
Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
de Rotte MC, de Jong PH, Pluijm SM, Calasan MB, Barendregt PJ, van Zeben D, van der Lubbe PA, de Sonnaville PB, Lindemans J, Hazes JM, de Jonge R. de Rotte MC, et al. Among authors: van zeben d. Arthritis Rheum. 2013 Nov;65(11):2803-13. doi: 10.1002/art.38113. Arthritis Rheum. 2013. PMID: 24166792 Free article. Clinical Trial.
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.
de Jong PH, Hazes JM, Han HK, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, van Schaeybroeck B, de Sonnaville PB, van Krugten MV, Luime JJ, Weel AE. de Jong PH, et al. Among authors: van zeben d. Ann Rheum Dis. 2014 Jul;73(7):1331-9. doi: 10.1136/annrheumdis-2013-204788. Epub 2014 May 1. Ann Rheum Dis. 2014. PMID: 24788619 Free PMC article. Clinical Trial.
43 results
Jump to page
Feedback